These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17335720)

  • 21. Mefloquine-induced trigeminal sensory neuropathy.
    Watt-Smith S; Mehta K; Scully C
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):163-5. PubMed ID: 11505262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mefloquine-induced psychosis.
    Havaldar PV; Mogale KD
    Pediatr Infect Dis J; 2000 Feb; 19(2):166-7. PubMed ID: 10694009
    [No Abstract]   [Full Text] [Related]  

  • 23. [Mefloquine: neuropsychiatric adverse effects are often severe and persistent long after withdrawal of the drug].
    Jensen JJ
    Ugeskr Laeger; 1998 Apr; 160(16):2413. PubMed ID: 9616091
    [No Abstract]   [Full Text] [Related]  

  • 24. Cutaneous vasculitis associated with mefloquine.
    White AC; Gard DA; Sessoms SL
    Ann Intern Med; 1995 Dec; 123(11):894. PubMed ID: 7486482
    [No Abstract]   [Full Text] [Related]  

  • 25. Safety of mefloquine in infants with acute falciparum malaria.
    Dubos F; Delattre P; Demar M; Carme B; Gendrel D
    Pediatr Infect Dis J; 2004 Jul; 23(7):679-81. PubMed ID: 15247612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First-time diagnosis of severe depression: induced by mefloquine?
    Whitworth AB; Aichhorn W
    J Clin Psychopharmacol; 2005 Aug; 25(4):399-400. PubMed ID: 16012293
    [No Abstract]   [Full Text] [Related]  

  • 27. Adverse events associated with mefloquine. Manufacturer should also give incidence of "severe" adverse events.
    Traer-Clark L
    BMJ; 1996 Dec; 313(7071):1553; author reply 1554. PubMed ID: 8978257
    [No Abstract]   [Full Text] [Related]  

  • 28. [A case report. Thrombocytopenia and granulomatous hepatitis caused by quinine].
    Horney E; Lagerstedt C; Wadenvik H
    Lakartidningen; 1996 Jan; 93(5):361-4. PubMed ID: 8628066
    [No Abstract]   [Full Text] [Related]  

  • 29. Mefloquine and scuba diving.
    Wright D
    N Z Med J; 1995 Dec; 108(1013):514. PubMed ID: 8532239
    [No Abstract]   [Full Text] [Related]  

  • 30. Mefloquine adverse effects with atypical facial lesions in an overweight patient.
    Descloux E; De Monbrison F; Basselin C; Vial T; Peyron F
    Travel Med Infect Dis; 2010 Sep; 8(5):318-21. PubMed ID: 20971443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse events associated with mefloquine. Study in returned travellers confirms authors' findings.
    Corbett EL; Doherty JP; Behrens RH
    BMJ; 1996 Dec; 313(7071):1552. PubMed ID: 8978255
    [No Abstract]   [Full Text] [Related]  

  • 32. [Convulsions during prophylactic use of mefloquine].
    Heeringa M; Kuster JA; Meyboom RH; Bouvy M
    Ned Tijdschr Geneeskd; 1998 Nov; 142(45):2477-80. PubMed ID: 10028330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mefloquine--a brief review.
    Ruff T
    Aust Fam Physician; 1996 May; 25(5):793. PubMed ID: 8935556
    [No Abstract]   [Full Text] [Related]  

  • 34. Bipolar disorder after mefloquine treatment.
    Even C; Friedman S; Lanouar K
    J Psychiatry Neurosci; 2001 May; 26(3):252-3. PubMed ID: 11394195
    [No Abstract]   [Full Text] [Related]  

  • 35. Mefloquine: persistent vestibular disorders.
    Prescrire Int; 2014 Jun; 23(150):157. PubMed ID: 25121152
    [No Abstract]   [Full Text] [Related]  

  • 36. [Encephalopathy and memory disorders during treatments with mefloquine].
    Marsepoil T; Petithory J; Faucher JM; Ho P; Viriot E; Benaiche F
    Rev Med Interne; 1993; 14(8):788-91. PubMed ID: 8191092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Convulsions during prophylactic use of mefloquine].
    Voskuil PH
    Ned Tijdschr Geneeskd; 1999 Jan; 143(5):273-4. PubMed ID: 10086156
    [No Abstract]   [Full Text] [Related]  

  • 38. Malaria, mefloquine and the mind.
    Ingram RJ; Ellis-Pegler RB
    N Z Med J; 1997 Apr; 110(1042):137-8. PubMed ID: 9152353
    [No Abstract]   [Full Text] [Related]  

  • 39. A unique case of mefloquine-induced psoriasis.
    Potasman I; Seligmann H
    J Travel Med; 1998 Sep; 5(3):156. PubMed ID: 9882160
    [No Abstract]   [Full Text] [Related]  

  • 40. Uncertainty about mefloquine will take time to resolve.
    Choo V
    Lancet; 1996 Mar; 347(9005):891. PubMed ID: 8622401
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.